Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 178OTHER 171NIH 13NETWORK 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 37Other 2Breast 2Thoracic 1Gastrointestinal 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 89Lung Neoplasms 78Small Cell Lung Carcinoma 28Adenocarcinoma of Lung 8Mesothelioma, Malignant 6Esophageal Neoplasms 6Carcinoma, Hepatocellular 4Adenocarcinoma 4Stomach Neoplasms 3Neoplasm Metastasis 3NSCLC 3Motor Activity 3Mesothelioma 3Meningeal Carcinomatosis 3Carcinoma, Renal Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Thymoma 2Sarcopenia 2Pancreatic Neoplasms 2Neuroendocrine Tumors 2Neoplasms 2Melanoma 2Lung Diseases 2EGFR Positive Non-small Cell Lung Cancer 2Disease 2Colorectal Neoplasms 2Weight Loss 1Untreated Advanced Non-small Cell Lung Cancer 1Unresectable Non-small Cell Lung Cancer 1

Interventions

Gefitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Head and Neck Neoplasms × Thoracic × Clear all
NCT01405846 2016-08-19

TIDAL1

Papworth Hospital NHS Foundation Trust

Phase 2 Terminated
32 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡